Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

BACKGROUND: Systemic inflammation appears to play a role in the progression of numerous solid tumors by promoting tumor proliferation. Our current study aimed to evaluate the role of inflammatory markers in limited disease (LD) small-cell lung cancer (SCLC) patients undergoing thoracic chemoradiothe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Manag Res
Egile Nagusiak: Bernhardt, Denise, Aufderstrasse, Sophie, König, Laila, Adeberg, Sebastian, Bozorgmehr, Farastuk, Christopoulos, Petros, Shafie, Rami A El, Hörner-Rieber, Juliane, Kappes, Jutta, Thomas, Michael, Herth, Felix, Steins, Martin, Debus, Jürgen, Rieken, Stefan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280890/
https://ncbi.nlm.nih.gov/pubmed/30555261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S180990
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak